These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36966453)

  • 21. Polymyositis and dermatomyositis - challenges in diagnosis and management.
    Yang SH; Chang C; Lian ZX
    J Transl Autoimmun; 2019 Dec; 2():100018. PubMed ID: 32743506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus.
    Bindra J; Chopra I; Hayes K; Niewoehner J; Panaccio M; Wan GJ
    Adv Ther; 2023 Jan; 40(1):194-210. PubMed ID: 36266383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic inflammatory myopathies.
    van der Kooi AJ; de Visser M
    Handb Clin Neurol; 2014; 119():495-512. PubMed ID: 24365315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Retrospective Medical Record Review of Utilization Patterns and Medical Resource Use Associated with Repository Corticotropin Injection among Patients with Rheumatologic Diseases in the United States.
    Nelson WW; Philbin MJ; Gallagher JR; Heap K; Carroll S; Wan GJ
    Rheumatol Ther; 2017 Dec; 4(2):465-474. PubMed ID: 29071588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and treatment of the idiopathic inflammatory myopathies.
    Gazeley DJ; Cronin ME
    Ther Adv Musculoskelet Dis; 2011 Dec; 3(6):315-24. PubMed ID: 22870489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups.
    Rothwell S; Cooper RG; Lundberg IE; Miller FW; Gregersen PK; Bowes J; Vencovsky J; Danko K; Limaye V; Selva-O'Callaghan A; Hanna MG; Machado PM; Pachman LM; Reed AM; Rider LG; Cobb J; Platt H; Molberg Ø; Benveniste O; Mathiesen P; Radstake T; Doria A; De Bleecker J; De Paepe B; Maurer B; Ollier WE; Padyukov L; O'Hanlon TP; Lee A; Amos CI; Gieger C; Meitinger T; Winkelmann J; Wedderburn LR; Chinoy H; Lamb JA;
    Ann Rheum Dis; 2016 Aug; 75(8):1558-66. PubMed ID: 26362759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.
    Moghadam-Kia S; Oddis CV; Aggarwal R
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):81-87. PubMed ID: 26767526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct binding and signaling activity of Acthar Gel compared to other melanocortin receptor agonists.
    Huang YJ; Galen K; Zweifel B; Brooks LR; Wright AD
    J Recept Signal Transduct Res; 2021 Oct; 41(5):425-433. PubMed ID: 32938265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
    Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis.
    Hayes K; Niewoehner J; Rice JB; Downes N; Hagopian E; Ma I; Wan GJ
    Adv Ther; 2023 Nov; 40(11):4999-5015. PubMed ID: 37728695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis.
    Mandel DE; Malemud CJ; Askari AD
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes.
    Kutz C
    Ther Adv Chronic Dis; 2016 Jul; 7(4):190-7. PubMed ID: 27433309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus.
    Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S
    Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interstitial Lung Disease in Polymyositis and Dermatomyositis.
    Long K; Danoff SK
    Clin Chest Med; 2019 Sep; 40(3):561-572. PubMed ID: 31376891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.
    Venalis P; Lundberg IE
    Rheumatology (Oxford); 2014 Mar; 53(3):397-405. PubMed ID: 23970542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients.
    Houtman M; Ekholm L; Hesselberg E; Chemin K; Malmström V; Reed AM; Lundberg IE; Padyukov L
    Arthritis Res Ther; 2018 Aug; 20(1):188. PubMed ID: 30157932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus.
    Askanase AD; Wright D; Zhao E; Zhu J; Bilyk R; Furie RA
    Rheumatol Ther; 2021 Dec; 8(4):1871-1886. PubMed ID: 34478124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
    BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repository corticotropin injection attenuates collagen-induced arthritic joint structural damage and has enhanced effects in combination with etanercept.
    Decker DA; Higgins P; Hayes K; Bollinger C; Becker P; Wright D
    BMC Musculoskelet Disord; 2020 Aug; 21(1):586. PubMed ID: 32867752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and diagnostic tools in idiopathic inflammatory myopathies.
    Tsamis KI; Boutsoras C; Kaltsonoudis E; Pelechas E; Nikas IP; Simos YV; Voulgari PV; Sarmas I
    Crit Rev Clin Lab Sci; 2022 Jun; 59(4):219-240. PubMed ID: 34767470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.